Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDSIsao Tawara, Hiroshi Shiku, Shinichi Kageyama et al.|Blood|2017Cited by 169
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, David G. Maloney, Hailing Lu et al.|Clinical Immunology|2004Cited by 66
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.Naoya Katsuyama, Yoshiki Akatsuka|PubMed|2023Cited by 2
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, David G. Maloney, Zhuo Zhao et al.|Transplantation and Cellular Therapy|2005Cited by 1